REGULATORY INTELLIGENCE·Recall
GlaxoSmithKline's Tivicay PD Recall: Labeling Error Impacts HIV Medication Supply Chain
GlaxoSmithKline LLC initiated a Class III recall for 463 cartons of Tivicay PD (dolutegravir sodium) 5mg tablets due to an incorrect carton expiration date. This event, now terminated, underscores critical pharmaceutical labeling and quality control vulnerabilities for procurement, regulatory, and supply chain leaders.
90-Day Activity